Search

The aquaculture industry continues to move toward phage therapy; here's a recent review published in Antibiotics by Justyna Kowalska (Proteon Pharmaceuticals) colleagues. Read the highlights in this article on The Fish Site.

Intralytix is recruiting patients for its Crohn's disease clinical trial out of Mount Sinai Hospital in New York. They will be evaluating patient stool samples for presence of adherent invasive E. coli (AIEC), and if positive, patients will

Intralytix has been issued a US patent covering its Shigella phages and their various formulations and applications (US Patent # 10,711,252), including improving food safety and human health, maintaining healthy gut microflora by modulating

Eligo Bioscience was awarded funding from CARB-X to develop CRISPR-based phage therapeutics (up to $1.82 million now, and up to $7.05 million if project milestones are met). This is the first CRISPR-based phage project CARB-X has funded.

Armata Pharmaceuticals just received a $15 million award from the US Department of Defense to take its Staphylococcus aureus phage cocktail to phase 1b/2 clinical trials.

Intralytix is a phage company in Maryland, USA that began in 1998 developing phage products for food; recently they've moved toward human therapy. Read about their recent progress here, including their new NIAID-funded Shigella phage clinic

Adaptive Phage Therapeutics and the Mayo Clinic have announced a collaboration to commercialize a phage susceptibility test. The test will enable rapid identification of patient-specific phages for therapy (based on screening hundreds of ca

Check out how the US Army's Combat Capabilities Development Command (CCDC) Chemical Biological Center is making use of a polymerized phage in biomanufacturing of BioCNFs, a black carbon material like charcoal that can help break up mustard

Check out these two new phage-related podcast episodes: Dr. Steffanie Strathdee, Co-Director of the Center for Innovative Phage Applications and Therapeutics (IPATH) discusses AMR on "This Podcast Will Kill You", and "The Bio Report" talks

Check out how the US Army's Combat Capabilities Development Command (CCDC) Chemical Biological Center is making use of a polymerized phage in biomanufacturing of BioCNFs, a black carbon material like charcoal that can help break up mustard

Check out these two new phage-related podcast episodes: Dr. Steffanie Strathdee, Co-Director of the Center for Innovative Phage Applications and Therapeutics (IPATH) discusses AMR on "This Podcast Will Kill You", and "The Bio Report" talks

Phages went to space, and now they're back! In a blog post, researchers from the University of Wisconsin-Madison and Rhodium Scientific describe their study of phage-host interactions and evolution in microgravity (using the spaceflight env

A new phage-based skincare product has been released! Wild Resilience Active Phage Serum, made by California biotech company Ellis Day Skin Science, contains a blend of two phages (called 'Cutiphage'). This is the company's first product. R

OmniLytics, a US biotech company developing phage-based products for crops (a subsidiary of PhageLux AgriHealth) has entered a new partnership with DCM, one of Europe's leading plant care companies. DCM will sell Omnilytics' phage products

A new phage-based skincare product has been released! Wild Resilience Active Phage Serum, made by California biotech company Ellis Day Skin Science, contains a blend of two phages (called 'Cutiphage'). This is the company's first product. R

Phages went to space, and now they're back! In a blog post, researchers from the University of Wisconsin-Madison and Rhodium Scientific describe their study of phage-host interactions and evolution in microgravity (using the spaceflight env

OmniLytics, a US biotech company developing phage-based products for crops (a subsidiary of PhageLux AgriHealth) has entered a new partnership with DCM, one of Europe's leading plant care companies. DCM will sell Omnilytics' phage products